176.37
price down icon1.05%   -1.88
after-market After Hours: 176.37
loading
Becton Dickinson Co stock is traded at $176.37, with a volume of 4.69M. It is down -1.05% in the last 24 hours and down -0.73% over the past month. Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$178.25
Open:
$177.37
24h Volume:
4.69M
Relative Volume:
1.47
Market Cap:
$50.55B
Revenue:
$20.87B
Net Income/Loss:
$1.50B
P/E Ratio:
33.66
EPS:
5.24
Net Cash Flow:
$2.59B
1W Performance:
-4.83%
1M Performance:
-0.73%
6M Performance:
-28.77%
1Y Performance:
-25.27%
1-Day Range:
Value
$174.49
$177.45
1-Week Range:
Value
$174.49
$185.44
52-Week Range:
Value
$163.33
$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Name
Name
Becton Dickinson Co
Name
Phone
(201) 847-6800
Name
Address
ONE BECTON DR, FRANKLIN LAKES
Name
Employee
74,000
Name
Twitter
@BDandCo
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
BDX's Discussions on Twitter

Compare BDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
176.37 51.09B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
483.12 172.46B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.87 43.30B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
279.20 39.87B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
239.26 17.20B 2.90B 467.20M 306.90M 6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-22-25 Downgrade Citigroup Buy → Neutral
May-02-25 Downgrade Goldman Buy → Neutral
May-02-25 Downgrade Piper Sandler Overweight → Neutral
May-02-25 Downgrade Raymond James Outperform → Mkt Perform
May-01-25 Downgrade BofA Securities Buy → Neutral
May-01-25 Downgrade Wells Fargo Overweight → Equal Weight
May-01-25 Downgrade William Blair Outperform → Mkt Perform
Oct-01-24 Upgrade Citigroup Neutral → Buy
May-30-24 Initiated Goldman Buy
Jul-24-23 Upgrade Raymond James Mkt Perform → Outperform
May-30-23 Resumed Morgan Stanley Overweight
May-05-23 Upgrade Piper Sandler Neutral → Overweight
Apr-12-23 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jan-03-23 Upgrade BofA Securities Neutral → Buy
Dec-12-22 Upgrade Citigroup Sell → Neutral
Jul-11-22 Downgrade Citigroup Neutral → Sell
Jun-24-22 Upgrade Wells Fargo Equal Weight → Overweight
Mar-18-22 Resumed Raymond James Mkt Perform
Mar-02-22 Resumed BofA Securities Neutral
Dec-08-21 Downgrade Piper Sandler Overweight → Neutral
Aug-06-21 Downgrade JP Morgan Overweight → Neutral
May-25-21 Initiated Barclays Equal Weight
Dec-15-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-15-20 Downgrade Wells Fargo Overweight → Equal Weight
Jul-09-20 Upgrade Barclays Equal Weight → Overweight
Jun-01-20 Resumed Goldman Buy
Mar-05-20 Initiated Citigroup Neutral
Feb-07-20 Downgrade Cowen Outperform → Market Perform
Feb-07-20 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20 Downgrade Raymond James Strong Buy → Outperform
Feb-06-20 Downgrade Cowen Outperform → Market Perform
Jan-08-20 Downgrade Barclays Overweight → Equal Weight
May-13-19 Upgrade Barclays Equal Weight → Overweight
Dec-07-18 Initiated Deutsche Bank Buy
Oct-16-18 Initiated Barclays Equal Weight
Jun-21-18 Upgrade JP Morgan Neutral → Overweight
Apr-10-18 Upgrade Citigroup Neutral → Buy
Jan-19-18 Resumed BofA/Merrill Buy
Jan-05-18 Upgrade Citigroup Sell → Neutral
Jan-05-18 Initiated KeyBanc Capital Mkts Overweight
Jan-03-18 Initiated Evercore ISI Outperform
Dec-29-17 Reiterated Deutsche Bank Buy
View All

Becton Dickinson Co Stock (BDX) Latest News

pulisher
Jul 31, 2025

Becton Dickinson Stock Dives 1.81% Amid 100.16% Volume Spike to $670M Ranking 199th in Market Activity as FDA Submission Drives Volatility - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline - Yahoo Finance

Jul 31, 2025
pulisher
Jul 30, 2025

Becton Dickinson receives FDA clearance for BD Veritor System for SARS-CoV-2 - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

BD's New FDA-Cleared COVID Test Delivers Results in Just 15 Minutes: What Healthcare Providers Should Know - Stock Titan

Jul 30, 2025
pulisher
Jul 28, 2025

Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal

Jul 28, 2025
pulisher
Jul 27, 2025

Is Becton Dickinson and Company stock overvalued or undervaluedBuild wealth faster with high-performing stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Becton Dickinson and Company in the next 12 monthsAchieve breakthrough financial growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Becton Dickinson, BNY, Incyte, Duolingo, Jabil: Major Stock Sales Unveiled! - TipRanks

Jul 26, 2025
pulisher
Jul 25, 2025

Earnings Preview: What To Expect From Becton, Dickinson And Company's Report - Barchart.com

Jul 25, 2025
pulisher
Jul 24, 2025

Becton, Dickinson and Co’s PUREST Study: A New Era in Urine Management - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Becton Dickinson Surges to 247th in Trading Volume with $477 Million in Shares Traded - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Becton Dickinson and Company stock priceBreakthrough financial growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - Quantisnow

Jul 23, 2025
pulisher
Jul 23, 2025

Is Becton Dickinson and Company a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Becton Dickinson & Co To Go Ex-Dividend On September 8th, 2025 With 1.04 USD Dividend Per Share - 富途牛牛

Jul 23, 2025
pulisher
Jul 22, 2025

Becton Dickinson Investors Seek Final OK Of $9M Deal - Law360

Jul 22, 2025
pulisher
Jul 22, 2025

Top Executive Sells Over a Thousand Shares of Becton Dickinson Stock! - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Becton Dickinson & Co Slips to 346th in Trading Volume Despite 3.39% Stock Price Gain - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

BD Shareholders to Receive $4.16 Annual Dividend: Next Quarterly Payment Details Revealed - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Jim Cramer Notes Becton Dickinson Stock Recently “Finished in the Black” - MSN

Jul 22, 2025
pulisher
Jul 20, 2025

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

The Smartest Dividend Stock to Buy With $1,000 Right Now - The Motley Fool

Jul 20, 2025
pulisher
Jul 18, 2025

Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance

Jul 18, 2025
pulisher
Jul 16, 2025

BD issues voluntary recall on certain Alaris infusion pump modules - MassDevice

Jul 16, 2025
pulisher
Jul 16, 2025

BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $190 - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX) - 富途牛牛

Jul 16, 2025
pulisher
Jul 15, 2025

Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $196 - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

BD issues update to recall of Alaris & BD Alaris pump modules - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated) - NJBIZ

Jul 15, 2025
pulisher
Jul 15, 2025

Waters to acquire BD flow cytometry business in a deal valued at $17.5 billion - C&EN

Jul 15, 2025
pulisher
Jul 15, 2025

Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

How Do Investors Really Feel About Becton Dickinson? - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

Becton Dickinson stock holds steady as TD Cowen maintains $183 price target By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Becton Dickinson stock holds steady as TD Cowen maintains $183 price target - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView

Jul 15, 2025
pulisher
Jul 15, 2025

Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Becton Dickinson’s Hold Rating Amid Strategic Moves and Limited Immediate Upside - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

TD Cowen Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $183 - 富途牛牛

Jul 15, 2025
pulisher
Jul 14, 2025

Waters, BD’s Biosciences & Diagnostic Solutions to combine - Medical Buyer

Jul 14, 2025
pulisher
Jul 14, 2025

A Big Move By Waters Corporation And Becton, Dickinson And Company (NYSE:WAT) - Seeking Alpha

Jul 14, 2025
pulisher
Jul 14, 2025

William Blair Maintains Becton Dickinson & Co(BDX.US) With Hold Rating - 富途牛牛

Jul 14, 2025
pulisher
Jul 14, 2025

BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech

Jul 14, 2025
pulisher
Jul 14, 2025

$17.5B Deal Combines Waters with BD’s Biosciences and Diagnostics Business - Genetic Engineering and Biotechnology News

Jul 14, 2025
pulisher
Jul 14, 2025

Becton Dickinson Announces Reverse Morris Trust with Waters - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar

Jul 14, 2025
pulisher
Jul 14, 2025

Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe

Jul 14, 2025
pulisher
Jul 14, 2025

Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC

Jul 14, 2025
pulisher
Jul 14, 2025

Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald

Jul 14, 2025
pulisher
Jul 14, 2025

Waters, BD Biosciences & Diagnostic Solutions to combine in $17.5B deal - MassDevice

Jul 14, 2025

Becton Dickinson Co Stock (BDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Becton Dickinson Co Stock (BDX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Garrison Michael David
EVP & President, Medical
Jul 18 '25
Sale
180.29
1,185
213,645
4,887
medical_instruments_supplies ALC
$87.87
price up icon 0.37%
medical_instruments_supplies RMD
$279.20
price up icon 2.67%
medical_instruments_supplies WST
$239.26
price up icon 0.00%
$67.16
price up icon 0.51%
medical_instruments_supplies COO
$70.87
price up icon 0.25%
Cap:     |  Volume (24h):